Categories: UniversityWebsite
We develop precision medicines to modulate macrophages for the treatment of cancer, by bringing together world-leading cancer biologists.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.07.2021 | - | $5.92M | - |
Mentions in press and media 6
| Date | Title | Description |
| 04.02.2022 | Annual #21toWatch announces shortlist in advance of return to in-person awards event | Next month’s coveted #21toWatch Awards announces 2022 shortlist, featuring some of the most ground-breaking entrepreneurs, startups and innovations from the East of England.
After presenting the Top21 awards virtually for the last two years... |
| 04.02.2022 | Annual #21toWatch announces shortlist in advance of return to in-person awards event | Annual #21toWatch announces shortlist in advance of return to in-person awards event
04-02-2022
Next month’s coveted #21toWatch Awards announces 2022 shortlist, featuring some of the most ground-breaking entrepreneurs, startups and innovati... |
| 02.02.2022 | Investment in Scottish Scale-ups Doubled in 2021, New Figures Show | Venture capital investment in Scottish scale-ups more than doubled last year, according to new figures from KPMG.
Statistics from the latest Venture Pulse Survey reveal Scottish scale-ups raised £626.9 million in venture capital funding acr... |
| 05.08.2021 | The DIGIT Deal Roundup Column | July 2021 Edition | Investment and Funding Scottish National Investment Bank and Forev
The Scottish National Investment Bank has announced it will invest £2m in electric vehicle charging firm Forev.
According to the bank, the investment boost will support the ... |
| 30.07.2021 | Macomics Raises £4.24M in Funding | Macomics, an Edinburgh, Scotland & Cambridge, UK-based immuno-oncology company, raised £4.24M in funding.
The round, which brought total funding raised to date to £7.44m, was led by Epidarex Capital with participation from new investor ... |
| 29.07.2021 | Macomics, the Macrophage-based Drug Discovery company, secures £4.24m expansion financing, and appoints CEO, CSO and VP Immunology | Macomics Ltd, an immuno-oncology company with world-leading expertise in macrophage biology, announces today that it has closed a follow-on financing of £4.24 million from its 2020 Seed round, bringing the total amount raised to £7.44m.
The... |
Reviews 0
